RecruitingNot ApplicableNCT05822024

Promoting Pupils' Physical Literacy


Sponsor

Center for Clinical Research and Prevention

Enrollment

336 participants

Start Date

Feb 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This pilot study aims to test the feasibility and acceptability of a previously developed and tested physical literacy (PL) intervention. A promising and internationally tested intervention, the Youth Physical Activity Towards Health (Y PATH), is based on the theory of PL and has proven to be effectful on children's PA levels and motor skills The Promoting Pupils' Physical Literacy (3 PL) project aims to test the feasibility and acceptability of the previously developed and tested Y-PATH intervention in a Danish context among a pupils (9 11 years of age). The hypothesis is that a revised 3 PL intervention protocol, aiming to increase pupils' PL, is ready for effectiveness testing by the end of this project.


Eligibility

Min Age: 8 YearsMax Age: 13 Years

Inclusion Criteria6

  • School/class-level
  • Non-special needs municipal school classes
  • Classes that are not in other school development or research projects which would most likely influence and bias the results
  • Pupil-level
  • Pupils with parents/guardians who have provided written informed consent, allowing their child to participate
  • Pupils who have provide an oral assessment

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPromoting Pupils' Physical Literacy Intervention

The physical literacy intervention 3PL is based on activities, games, and modifications of the physical education classes to target and enhance pupils' physical literacy.


Locations(3)

Center for Clinical Research and Prevension, Frederiksberg and Bispebjerg Hospital

Copenhagen, Frederiksberg, Denmark

University of Copenhagen

Copenhagen, Nørrebro, Denmark

University of Southern Denmark

Odense, Odense M, Denmark

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05822024


Related Trials